Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyncée Tec is a Swiss life-science tools and optical metrology company that develops and commercializes Digital Holographic Microscopy (DHM) systems for label-free, non-invasive imaging and quantitative analysis. Its instruments are used in biological imaging applications such as live-cell phenotyping, cell viability, confluency, dry mass measurement, 4D tracking, cardiomyocyte beating analysis, spheroid and organoid imaging, and cytotoxicity screening, as well as in materials science and industrial metrology. The company also offers customized and OEM DHM modules in addition to standard benchtop systems. Founded out of EPFL-related research, Lyncée Tec built a global distributor network and established itself as a pioneer in quantitative phase imaging. In 2025, it was acquired by Park Systems and continues to operate within Park's digital holographic microscopy portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyncée Tec.